Changeflow GovPing Healthcare & Life Sciences Cannula Insertion Mechanism, EP4257163A2, mylif...
Routine Notice Added Final

Cannula Insertion Mechanism, EP4257163A2, mylife Diabetes Care

Email

Summary

The EPO published patent application EP4257163A2 titled 'Cannula Insertion Mechanism' filed by mylife Diabetes Care AG, published April 15, 2026. Inventors listed are Buri, Thomas; Hostettler, Patrick; Hofer, Christophe; Streit, Ursina; Staub, Seline; and Steck, Jürg. The application is classified under IPC A61M 5/32, A61M 5/158, and A61M 5/142, covering medical device mechanisms for subcutaneous cannula insertion. Designated states cover most EU/EEA member states plus the United Kingdom and other EPC contracting states.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Medical Devices (A61M) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 66 changes logged to date.

What changed

The EPO published patent application EP4257163A2 for a Cannula Insertion Mechanism filed by mylife Diabetes Care AG. The application covers medical device mechanisms used for inserting subcutaneous cannulas, with IPC classifications in A61M 5/32, A61M 5/158, and A61M 5/142. The publication designates all major EU and EEA contracting states, as well as the United Kingdom. This is a publication of a patent application, not a granted patent or regulatory requirement — it creates no compliance obligations for any party.

For competitors in the diabetes care or medical device sectors, this publication signals that mylife Diabetes Care AG is pursuing intellectual property protection for a cannula insertion mechanism. Competitors developing similar technologies should review the application's claims for potential overlap and consider their own IP strategies accordingly.

Archived snapshot

Apr 25, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

CANNULA INSERTION MECHANISM

Publication EP4257163A2 Kind: A2 Apr 15, 2026

Applicants

mylife Diabetes Care AG

Inventors

Buri, Thomas, Hostettler, Patrick, Hofer, Christophe, Streit, Ursina, Staub, Seline, Steck, Jürg

IPC Classifications

A61M 5/32 20060101AFI20231115BHEP A61M 5/158 20060101ALI20231115BHEP A61M 5/142 20060101ALI20231115BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Medical Devices (A61M)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Instrument
Notice
Branch
International
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4257163A2

Who this affects

Applies to
Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent filing Medical device innovation
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Regulatory Affairs
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when EPO Patent Bulletin - Medical Devices (A61M) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!